Menu Back to DIA-India-9th-Pharmacovigilance-Conference

Overview

Evolution is inevitable and over a decade there has been magnificent evolution in Human, Machine, Process & regulation to deliver one goal- bring safer and cost-effective drugs to patients. Is PV embarking this journey of evolution to improve patient life by supporting pharmaceutical organizations to be more future ready and breaking boundaries of drug development?

DIA India is thrilled to announce the most awaited Pharmacovigilance Conference in the region - the 9th edition of our Annual Pharmacovigilance Conference Themed Evolving Safety Ecosystem – Pharmacovigilance for tomorrow, to be held on June 2-3, 2022 in an entirely virtual format.

At this 9th Pharmacovigilance Conference DIA brings to you key speakers across the industry sharing insights on the changing PV landscape, expanding the vistas of Drug Safety in the light of Emergency usage of vaccines during pandemic to, ushering in Safe Personalised Medicines through advance Healthcare Science.

Who should attend?

  • Pharmacovigilance And Drug Safety
  • Risk Management
  • Pharmacovigilance Compliance
  • Regulatory Affairs
  • Medical Affairs
  • Late Phase Professionals Conducting PMS, Observational And Non-Interventional Studies
  • Real World Data And Real World Evidence
  • Technology Professionals

Learning objectives

  • Transactional to Transformational Safety Ecosystem - The Future of Pharmacovigilance
  • Managing Safety in Clinical setting
  • RWE / RWD
  • Learnings in PV Ops during a pandemic - Readiness to the future
  • Changing scenario for Drug Devices Combination in PV
  • Promise Vs Deliverables of AI in PV
  • From Risk Management to focussed Risk minimisation measures
  • Pragmatic approaches towards Trial related injuries causality assessment
  • Signal Management: Choice between Qualitative & Quantitative Analysis
  • Role of AI & Innovations in managing high volume for COVID-19 vaccines and therapeutics
  • Regulatory Intelligence - MDR regulations changes

Program Committee

  • Moin  Don
    Moin Don Founder & CEO, PVCON Consulting, Lead : South Asia Chapter (ISoP)
    International Society of Pharmacovigilance (ISoP), India
  • Krishna   Bahadursingh
    Krishna Bahadursingh Head of Patient Safety
    Bristol Myers Squibb, Japan
  • Prashant  Joshi, RPh
    Prashant Joshi, RPh Executive Director - Drug Safety
    Labcorp Drug Development, India
  • Ritu  Jaswal
    Ritu Jaswal Vice President- Pharmacovigilance Operations
    PAREXEL, India
  • Saket  Singh Kumar, MSc
    Saket Singh Kumar, MSc VP Global PV Capability Lead
    Accenture , India
  • J Vijay  Venkatraman, MD, MBA
    J Vijay Venkatraman, MD, MBA Managing Director and CEO
    Oviya MedSafe, India
  • Vijay  Bhargav
    Vijay Bhargav Vice President, Lifecycle Safety
    IQVIA , India
Load More

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download